XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) item	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Revenue recognition
Estimated contractual allowance	$ 4,600,000		$ 4,600,000		$ 6,200,000
Period for return of incorrect shipments			10 days
Number of times overstocking returns are limited | item			2
Period for return of product due to overstock			12 months
Maximum percentage of distributor's total purchase for the prior 12-month period			1.00%
Sales, net	14,336,569	$ 42,496,944	$ 59,078,919	$ 92,570,669
License revenue payable to patent owner, as a percent			50.00%
Syringes
Revenue recognition
Sales, net	11,397,728	40,290,601	$ 54,103,851	87,857,411
Blood Collection Products
Revenue recognition
Sales, net	561,502	482,108	1,850,565	1,093,466
Easy Point Needles
Revenue recognition
Sales, net	2,141,381	1,709,475	2,876,847	3,478,556
Other Products
Revenue recognition
Sales, net	235,958	14,760	247,656	141,236
U.S. sales
Revenue recognition
Sales, net	9,561,809	12,721,896	19,774,650	23,683,087
U.S. sales | Syringes
Revenue recognition
Sales, net	6,877,166	10,892,733	15,272,468	19,652,047
U.S. sales | Blood Collection Products
Revenue recognition
Sales, net	526,256	456,818	1,603,951	1,030,826
U.S. sales | Easy Point Needles
Revenue recognition
Sales, net	2,138,573	1,358,935	2,868,543	2,971,268
U.S. sales | Other Products
Revenue recognition
Sales, net	19,814	13,410	29,688	28,946
U.S. government
Revenue recognition
Sales, net		27,357,840	15,731,136	65,140,200
U.S. government | Syringes
Revenue recognition
Sales, net		27,357,840	15,731,136	65,140,200
North and South America (excluding U.S.)
Revenue recognition
Sales, net	4,313,128	1,512,388	15,390,256	2,459,616
North and South America (excluding U.S.) | Syringes
Revenue recognition
Sales, net	4,096,984	1,467,508	15,171,230	2,293,328
North and South America (excluding U.S.) | Easy Point Needles
Revenue recognition
Sales, net		44,880	2,608	56,848
North and South America (excluding U.S.) | Other Products
Revenue recognition
Sales, net	216,144		216,418	109,440
Other international sales
Revenue recognition
Sales, net	461,632	904,820	8,182,877	1,287,766
Other international sales | Syringes
Revenue recognition
Sales, net	423,578	572,520	7,929,017	771,836
Other international sales | Blood Collection Products
Revenue recognition
Sales, net	35,246	25,290	246,614	62,640
Other international sales | Easy Point Needles
Revenue recognition
Sales, net	$ 2,808	305,660	5,696	450,440
Other international sales | Other Products
Revenue recognition
Sales, net		$ 1,350	$ 1,550	$ 2,850

X

- Definition

The percentage of revenue from licensing agreements that is payable to the owner of certain patented technology under certain conditions.

+ References

No definition available.

+ Details

Name:	rvp_LicenseRevenuePercentagePayableToPatentOwner
Namespace Prefix:	rvp_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the maximum percentage of distributor's total purchase in prior 12-month period for overstock return.

+ References

No definition available.

+ Details

Name:	rvp_RevenueRecognitionMaximumPercentageOfDistributorsTotalPurchaseInPriorTwelveMonthPeriodForOverstockReturn
Namespace Prefix:	rvp_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of overstock returns available to a customer within a specified period of time.

+ References

No definition available.

+ Details

Name:	rvp_RevenueRecognitionOverstockReturnLimitNumber
Namespace Prefix:	rvp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The period of time specified for overstock returns.

+ References

No definition available.

+ Details

Name:	rvp_RevenueRecognitionOverstockReturnPeriod
Namespace Prefix:	rvp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the period for return of incorrect shipments, following arrival at the distributor's facility.

+ References

No definition available.

+ Details

Name:	rvp_RevenueRecognitionPeriodForReturnOfIncorrectShipments
Namespace Prefix:	rvp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 55
-Paragraph 27
-URI https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046

+ Details

Name:	us-gaap_ContractWithCustomerRefundLiabilityCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_ProductOrServiceAxis=rvp_SyringesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=rvp_BloodCollectionProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=rvp_EasyPointNeedlesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=rvp_OtherProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=rvp_U.s.GovernmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=rvp_NorthAndSouthAmericaExcludingUnitedStatesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=rvp_OtherInternationalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: